1st Quarter - Report
THE MCMANUS GROUP for ALLERGAN INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA approval and enforcement issues. MDUFA reauthorization. PDUFA reauthorization. Cosmetic safety issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Opposition to Part D rebates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Taxation/Internal Revenue Code TAX
Support for H.R. 436, "Protect Medical Innovation Act" and S.17, "Medical Device Access and Innovation Protection Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.